| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-82-6-733 |
| P698 | PubMed publication ID | 1138583 |
| P2093 | author name string | J. Sagel | |
| J. A. Colwell | |||
| M. Laimins | |||
| L. Crook | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | platelet aggregation | Q14913634 |
| internal medicine | Q11180 | ||
| P304 | page(s) | 733-738 | |
| P577 | publication date | 1975-06-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Increased platelet aggregation in early diabetus mellitus | |
| Increased Platelet Aggregation in Early Diabetus Mellitus | |||
| P478 | volume | 82 |
| Q72792254 | A study of platelet-relevant parameters in patients with diabetic microangiopathy |
| Q35625266 | Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus |
| Q70777748 | Acetylsalicylic acid and bleeding time in juvenile diabetes mellitus |
| Q28222271 | Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus |
| Q40282253 | Agonist regulation of the human platelet prostaglandin D2 receptor |
| Q41469500 | Alterations in Blood Elements in the Pathogenesis of Diabetic Retinopathy |
| Q44176618 | An etiologic model proposing that non-insulin-dependent diabetes mellitus is chronic hypoxic stress hyperglycemia |
| Q39696841 | Anti-platelet effects of long-term treatment with gliclazide in diabetic patients |
| Q36519064 | Antiplatelet agents and diabetic vascular disease. |
| Q37709191 | Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus |
| Q79756351 | Arterial wall cholesterol content is a predictor of development and severity of arterial thrombosis |
| Q69259818 | Augmented production of platelet-activating factor in human polymorphonuclear leukocytes by ketone bodies |
| Q39590604 | Beta Thromboglobulin and Glycosylated Haemoglobin in Diabetes Mellitus |
| Q39507362 | Changes in the blood platelets of alcoholics during alcohol withdrawal |
| Q71097270 | Changes of platelet phospholipids in diabetes mellitus |
| Q40108842 | Classification of platelet aggregation patterns with two ADP solutions (the double-ADP method) and its clinical application to diabetes mellitus |
| Q34714607 | Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2. |
| Q52355379 | Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets. |
| Q40746630 | Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with and without vascular disease |
| Q50903001 | Decreased activity of arachidonate 12-lipoxygenase in platelets of Japanese patients with non-insulin-dependent diabetes mellitus |
| Q70975653 | Decreased capacity to inhibit platelet hyperactivity and to stabilize prostacyclin of high-density lipoproteins in experimental diabetes |
| Q33608124 | Decreased expression of platelet human scavenger receptor class B type I in patients with type 2 diabetes mellitus |
| Q40263209 | Decreased platelet vitamin C in diabetes mellitus: Possible role in hyperaggregation |
| Q37184996 | Depressed antithrombin III biological activity in opiate addicts |
| Q51633906 | Determinants of ADP-induced platelet aggregation in diabetes mellitus. |
| Q38005018 | Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials |
| Q36319022 | Diabetes mellitus and the nervous system |
| Q54489626 | Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients. |
| Q70215906 | Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7 |
| Q70479417 | Effect of aspirin on platelet aggregation in diabetes mellitus |
| Q69360251 | Effect of eicosapentaenoic acid ethyl ester on proteinuria of streptozotocin-induced diabetes mellitus in rats |
| Q34526369 | Effect of indomethacin on basal and histamine stimulated human gastric acid secretion |
| Q77742216 | Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group |
| Q58823401 | Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors |
| Q70793020 | Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man |
| Q41198268 | Enhanced release of ‘PGI2-like’ substance in experimental hypertension |
| Q41846624 | Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects |
| Q72806694 | Factors Contributing to Platelet Hyperactivity in Diabetes Mellitus |
| Q68026981 | Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells |
| Q40258060 | Hypercoagulation and thrombosis |
| Q39769095 | Hyperosmolar Nonketotic Coma in the Elderly Diabetic |
| Q73384093 | Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease |
| Q39682769 | Increased biosynthesis of thromboxane A2by diabetic platelets |
| Q40873243 | Increased incidence of moderate stenosis among patients with diabetes: substrate for myocardial infarction? |
| Q44555142 | Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy |
| Q34562053 | Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus |
| Q67469715 | Increased prostaglandin synthesis in childhood diabetes mellitus |
| Q93092007 | Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E-Deficient Mice |
| Q53359026 | Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. |
| Q34506411 | Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling |
| Q35766245 | Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling. |
| Q42745390 | Low phospholipid arachidonic acid values in diabetic platelets |
| Q39578376 | Macrovascular disease and hyperinsulinaemia |
| Q38215838 | Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents. |
| Q72806697 | Methods for the Detection of Activated Platelets |
| Q41687438 | Multifactorial aspects of the treatment of the type II diabetic patient |
| Q33490306 | Myeloproliferative and metabolic causes |
| Q45076599 | Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: a controlled trial |
| Q42451736 | Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus |
| Q28196731 | Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects |
| Q90223553 | Parafoveal Nonperfusion Analysis in Diabetic Retinopathy Using Optical Coherence Tomography Angiography |
| Q33609530 | Perioperative problems in the diabetic |
| Q69126606 | Pharmacological treatment of lipid disorders in diabetes mellitus |
| Q41446070 | Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise |
| Q72699948 | Plasma beta-thromboglobulin in uncomplicated insulin-dependent diabetes at rest and during physical exercise |
| Q39770091 | Platelet Aggregation: Relevance to Thrombotic Tendencies |
| Q39769075 | Platelet Function and Diabetes Mellitus |
| Q39724325 | Platelet adhesion and aggregation in diabetes mellitus |
| Q69255325 | Platelet aggregability during the first two years of type 1 (insulin-dependent) diabetes mellitus in children |
| Q81322453 | Platelet aggregates in various stages of diabetic retinopathy: evaluation using the particle-counting light-scattering method |
| Q70935299 | Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography |
| Q45145031 | Platelet aggregation in patients with severe atherosclerosis |
| Q36335824 | Platelet function in diabetes mellitus |
| Q71063882 | Platelet hyperaggregability during alcohol withdrawal |
| Q44120096 | Platelet hyporesponsiveness to epinephrine in carriers of bartter's syndrome |
| Q70890407 | Platelet life-span in diabetics with and without retinopathy |
| Q66950527 | Platelet survival in diabetes mellitus using an aspirin-labelling technique |
| Q68125873 | Platelets and antiplatelet therapy in ischemic heart disease |
| Q54495461 | Platelets and vascular smooth muscle: Abnormalities of phosphodiesterase, aggregation, and cell growth in experimental and human diabetes |
| Q91704326 | Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs |
| Q39770084 | Rationale for Antiplatelet Agents in Diabetic Vascular Disease |
| Q45006545 | Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy |
| Q41083808 | Reduced guanine nucleotide-stimulated polyphosphoinositide specific phospholipase C in platelet hyperaggregation in IDDM |
| Q68171228 | Reduction of platelet aggregation induced by euglycaemic insulin clamp |
| Q70712701 | Relation of platelet phospholipids to diabetic control |
| Q39250719 | Role of blood platelets in coronary artery disease |
| Q39820647 | Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death |
| Q47734969 | Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients |
| Q72580517 | Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes |
| Q36841959 | Systematic review and meta-analysis of optimal P2Y12 blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome |
| Q37925009 | TRITON and beyond: new insights into the profile of prasugrel |
| Q66940902 | The Hypercoagulability States |
| Q83203081 | The diabetic foot |
| Q39894764 | The distribution of platelet contractile proteins in normal and streptozotocin diabetic rats |
| Q40651342 | The effect of oral glucose on von Willebrand factor activity in normal and diabetic subjects |
| Q39876046 | The effect of streptozotocin diabetes on platelet function in rats |
| Q39800664 | The role of platelets in thrombotic and vascular disease |
| Q72717830 | Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin |
| Q28191802 | Treatment for the procoagulant state in type 2 diabetes |
| Q41841791 | Vascular leucocyte adhesion molecules unaltered in the human retina in diabetes |
| Q54120661 | [Heart pathology of extracardiac origin. XI. Cardiac repercussions of diabetes mellitus] |
Search more.